Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2026 | Rhythm monitoring after stroke: current guidelines and looking to the future

Tobias Uhe, MD, University Hospital Leipzig, Leipzig, Germany, comments on the future of rhythm monitoring after stroke, noting that current guidelines recommend anticoagulation for patients with atrial fibrillation and a high VASc score. Dr Uhe expects the results of the FIND-AF2 study (NCT04371055) in 2027, which may show that prolonged rhythm monitoring reduces the risk of recurrent ischemic stroke, and suggests that consumer wearables could complement current monitoring strategies. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

As a cardiologist I would follow our current ESC guidelines and they say if you have a variable ECG with AF of 30 seconds you should handle this as AF and if there is a CHA₂DS₂-VASc score one or bigger one, you should anticoagulate this patient. I think in five years, we, of course, will have the results, the final results of FIND-AF2. We expect the results for 2027. And if we can show that intensified and prolonged rhythm monitoring reduces hard endpoints, such as recurrent ischemic stroke or systemic embolism...

As a cardiologist I would follow our current ESC guidelines and they say if you have a variable ECG with AF of 30 seconds you should handle this as AF and if there is a CHA₂DS₂-VASc score one or bigger one, you should anticoagulate this patient. I think in five years, we, of course, will have the results, the final results of FIND-AF2. We expect the results for 2027. And if we can show that intensified and prolonged rhythm monitoring reduces hard endpoints, such as recurrent ischemic stroke or systemic embolism. Wearables can play a role because they are patient-centered, they are accessible and I think they could easily complement current rhythm monitoring strategies.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.